Pages that link to "Q37400935"

The following pages link to Vaccines against morphine/heroin and its use as effective medication for preventing relapse to opiate addictive behaviors. (Q37400935):

Displaying 25 items.

• Future pharmacological treatments for substance use disorders (Q22242633) (← links)
• Facial recognition of heroin vaccine opiates: type 1 cross-reactivities of antibodies induced by hydrolytically stable haptenic surrogates of heroin, 6-acetylmorphine, and morphine (Q33874955) (← links)
• Liposomes containing monophosphoryl lipid A: a potent adjuvant system for inducing antibodies to heroin hapten analogs. (Q33994987) (← links)
• Novel pharmacotherapeutic strategies for treatment of opioid-induced neonatal abstinence syndrome (Q34081859) (← links)
• Can you vaccinate against substance abuse? (Q34132788) (← links)
• Novel cocaine vaccine linked to a disrupted adenovirus gene transfer vector blocks cocaine psychostimulant and reinforcing effects (Q34216479) (← links)
• Immunogenicity of individual vaccine components in a bivalent nicotine vaccine differ according to vaccine formulation and administration conditions (Q35061547) (← links)
• A conjugate vaccine attenuates morphine- and heroin-induced behavior in rats (Q35224297) (← links)
• Combined active and passive immunization against nicotine: Minimizing monoclonal antibody requirements using a target antibody concentration strategy (Q35476326) (← links)
• Pharmacokinetic strategies for treatment of drug overdose and addiction (Q35813574) (← links)
• An oxycodone conjugate vaccine elicits drug-specific antibodies that reduce oxycodone distribution to brain and hot-plate analgesia (Q35847661) (← links)
• Developing a vaccine against multiple psychoactive targets: a case study of heroin (Q35892296) (← links)
• Co-administration of morphine and oxycodone vaccines reduces the distribution of 6-monoacetylmorphine and oxycodone to brain in rats (Q36024799) (← links)
• Vaccines in the Treatment of Substance Abuse (Q36655861) (← links)
• A morphine conjugate vaccine attenuates the behavioral effects of morphine in rats (Q37172159) (← links)
• Levels of heroin and its metabolites in blood and brain extracellular fluid after i.v. heroin administration to freely moving rats (Q37219079) (← links)
• Effects of drugs of abuse on the central neuropeptide Y system (Q38436912) (← links)
• Efficacy of an adenovirus-based anti-cocaine vaccine to reduce cocaine self-administration and reacqusition using a choice procedure in rhesus macaques. (Q39327496) (← links)
• Structurally distinct nicotine immunogens elicit antibodies with non-overlapping specificities (Q40431126) (← links)
• Development of a Clinically Viable Heroin Vaccine. (Q45060547) (← links)
• Vaccines targeting drugs of abuse: is the glass half-empty or half-full? (Q46159546) (← links)
• Ethical Implications in Vaccine Pharmacotherapy for Treatment and Prevention of Drug of Abuse Dependence. (Q47852175) (← links)
• A morphine/heroin vaccine with new hapten design attenuates behavioral effects in rats (Q48876406) (← links)
• Enhancing Efficacy and Stability of an Antiheroin Vaccine: Examination of Antinociception, Opioid Binding Profile, and Lethality (Q50113262) (← links)
• In further defense of nonclinical abuse liability testing of biologics (Q93349493) (← links)